Topline A booster shot of the Pfizer/BioNTech Covid-19 vaccine provides sufficient protection against the omicron variant of the coronavirus, Pfizer and BioNTech announced Wednesday based on early results from an initial lab study of the variant, which also showed just receiving two shots of the vaccine may protect against severe illness from the variant, but may not sufficiently prevent infection. Safeway pharmacist Ashley McGee fills a syringe with the Pfizer COVID-19 booster vaccination on … [+] October 01, 2021 in San Rafael, California. Getty Images Key Facts The study found a third shot of the Pfizer vaccine showed a 25-fold increase in protection from omicron as compared with two doses of the vaccine, which is comparable to the protection two doses of the vaccine provides against the original “wild type” strain of the coronavirus without mutations. Booster shots also “strongly [increase]” T cell levels that correlate with protection against severe disease, Pfizer and BioNTech said. The… Click below to read the full story from Forbes
Read More
Pfizer/BioNTech Covid-19 Booster ‘Neutralizes’ Omicron Variant, Companies Say
